Neuropathology of cerebrovascular diseases

Seminars in Diagnostic Pathology

Volumn 26, Issue 2, 2009, Pages 103-115

  Hazrati, Lili Naz ^a   Bergeron, Catherine ^a   Butany, Jagdish ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Amyloid angiopathy; CADASIL; Cerebral vasculitis; Hemorrhagic infarction; Ischemic infarction; Vascular malformation

Indexed keywords

ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN ATHEROSCLEROSIS; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN VASCULITIS; CADASIL; CAVERNOUS HEMANGIOMA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DISEASE CLASSIFICATION; HUMAN; HYPERTENSION; MAEDA SYNDROME; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SACCULAR ANEURYSM; SUBARACHNOID HEMORRHAGE; VASCULAR AMYLOIDOSIS;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; HUMANS;

EID: 70349495632     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2009.08.002     Document Type: Article

References (125)

1. Longstreth W.T., Bernick C., Fitzpatrick A., et al. Frequency and predictors of stroke death in 5888 participants in the cardiovascular health study. Neurology 56 (2001) 368-375
2. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
3. Pappachan J., and Kirkham F.J. Cerebrovascular disease and stroke. Arch Dis Child 93 (2008) 890-898
4. Roach E.S., Golomb M.R., Adams R., et al. American Heart Association Stroke Council. Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: A scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39 (2008) 2644-2691
5. Flynn R.W., MacWalter R.S., and Doney A.S. The cost of cerebral ischaemia. Neuropharmacology 55 (2008) 250-256
6. Terent A. Trends in stroke morbidity. In: Whisnant J. (Ed). Stroke: Populations, Cohorts, and Clinical Trials (1993), Butterworth-Heineman, Oxford 37-58
7. Terent A. Trends in stroke incidence and 10-year survival, 1975-2001. Stroke 34 (2003) 1353-1358
8. Rafii M.S., and Hillis A.E. Compendium of cerebrovascular diseases. Int Rev Psychiatry 18 (2006) 395-407
9. Strong S.H., and Halperin J.L. Confronting atrial fibrillation in the elderly: Stroke risk stratification and emerging antithrombotic therapies. Geriatrics 62 (2007) 22-27
10. Badimon L., and Vilahur G. Platelets, arterial thrombosis and cerebral ischemia. Cerebrovasc Dis 24 suppl 1 (2007) 30-39
11. Bousser M.G., and Ferro J.M. Cerebral venous thrombosis: An update. Lancet Neurol 6 (2007) 162-170
12. Caplan L.R., and Fisher M. The endothelium, platelets, and brain ischemia. Rev Neurol Dis 4 (2007) 113-121
13. Kirkham F.J. Therapy insight: Stroke risk and its management in patients with sickle cell disease. Nat Clin Practice Neurol 3 (2007) 264-278
14. Scheid R., and Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 14 (2007) 483-493
15. Joubert J., Cumming T.B., and McLean A.J. Diversity of risk factors for stroke. J Neurol Sci 262 (2007) 71-76
16. Solenski N.J. Emerging risk factors for cerebrovascular disease. Curr Drug Targets 8 (2007) 802-816
17. Yang L.K., Wong K.C., Wu M.Y., et al. Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients. J Am Coll Nutr 26 (2007) 272-278
18. Zalba G., Fortuno A., San Jose G., et al. Oxidative stress, endothelial dysfunction and cerebrovascular disease. Cerebrovasc Dis 24 suppl 1 (2007) 24-29
19. Siennicki-Lantz A., Reinprecht F., Wollmer P., et al. Smoking-related changes in cerebral perfusion in a population of elderly men. Neuroepidemiology 30 (2008) 84-92
20. Tyas S.L., White L.R., Petrovitch H.W., et al. Mid-life smoking and late-life dementia: The Honolulu-Asia aging study. Neurobiol Aging 24 (2003) 589-596
21. Gil-Nunez A. The metabolic syndrome and cerebrovascular disease: Suspicion and evidence. Cerebrovasc Dis 24 suppl 1 (2007) 64-75
22. Hettema M.E., Bootsma H., and Kallenberg C.G. Macrovascular disease and atherosclerosis in SSc. Rheumatology 47 (2008) 578-583
23. Selvarajah D., and Tesfaye S. Central nervous system involvement in diabetes mellitus. Curr Diab Rep 6 (2006) 431-438
24. Betts J., Jaros E., Perry R.H., et al. Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 32 (2006) 359-373
25. Hegele R.A., and Dichgans M. Update on the genetics of stroke and cerebrovascular disease 2007. Stroke 39 (2008) 252-254
26. Natowicz M., and Kelley R.I. Mendelian etiologies of stroke. Ann Neurol 22 (1987) 175-192
27. Auer R.N., Wieloch T., Olsson Y., and Siesjø B.K. The distribution of hypoglycemic damage. Acta Neuropathol (Berl) 64 (1984) 177-191
28. Miyamoto O., and Auer R.N. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology 54 (2000) 362-371
29. Tanne D. Impaired glucose metabolism and cerebrovascular diseases. Adv Cardiol 45 (2008) 107-113
30. Esiri M.M., Wilcock G.K., and Morris J.H. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63 (1997) 749-753
31. Hulette C., Nochlin D., McKeel D., et al. Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. (see comment). Neurology 48 (1997) 668-672
32. Jellinger K.A., and Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci 257 (2007) 80-87
33. Kertesz A., and Chertkow H. Diagnosis and treatment of dementia. 2. Diagn CMAJ Can Med Assoc J 178 (2008) 825-836
34. Knopman D.S. Cerebrovascular disease and dementia. Br J Radiol 80 (2007) S121-S127
35. Mills S., Cain J., Purandare N., and Jackson A. Biomarkers of cerebrovascular disease in dementia. Br J Radiol 80 (2007) S128-S145
36. Murray M.E., Knopman D.S., and Dickson D.W. Vascular dementia: Clinical, neuroradiologic and neuropathologic aspects. Panminerva Med 49 (2007) 197-207
37. Onyike C.U. Cerebrovascular disease and dementia. Int Rev Psychiatry 18 (2006) 423-431
38. Qiu C., De Ronchi D., and Fratiglioni L. The epidemiology of the dementias: An update. Curr Opin Psychiatry 20 (2007) 380-385
39. Bestehorn K., Wahle K., and Kirch W. Stroke risk screening of adults with hypertension: Prospective cross-sectional study in primary care. Clin Drug Invest 28 (2008) 281-289
40. Grassi G., Arenare F., Trevano F.Q., et al. Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials. Curr Hypertens Rep 9 (2007) 299-304
41. Kemper T., Moss M.B., Hollander W., and Prusty S. Microinfarction as a result of hypertension in a primate model of cerebrovascular disease. Acta Neuropathol 98 (1999) 295-303
42. Lanari A., Silvestrelli G., De Dominicis P., et al. Arterial hypertension and cognitive dysfunction in physiologic and pathologic aging of the brain. Am J Geriatr Cardiol 16 (2007) 158-164
43. Nag S., and Robertson D.M. Cerebral cortical changes in acute experimental hypertension: An ultrastructural study. Lab Invest 36 (1977) 150-161
44. Papadopoulos D.P., and Papademetriou V. Aggressive blood pressure control and stroke prevention: Role of calcium channel blockers. J Hypertens 26 (2008) 844-852
45. Pedelty L., and Gorelick P.B. Management of hypertension and cerebrovascular disease in the elderly. Am J Med 121 suppl (2008) S23-S31
46. Skinhoj E., and Standgaard S. Pathogenesis of hypertensive encephalopathy. Lancet 1 (1973) 461-462
47. Chester E.M., Agamanolis D.P., Banker B.Q., and Victor M. Hypertensive encephalopathy: A clinicopathological study of 20 cases. Neurology 28 (1978) 928-939
48. Kemper T.L., Blatt G.J., Killiany R.J., and Moss M.B. Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol 101 (2001) 145-153
49. Torvik A., Svindland A., and Lindboe C.F. Pathogenesis of carotid thrombosis. Stroke 20 (1989) 1477-1483
50. Morita A., Nakayama T., and Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 19 (2006) 593-600
51. Tsimikas S., Aikawa M., Miller F.J., et al. Increased plasma oxidized phospholipids: Apolipoprotein B-100 ratio wih concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: A potential biomarker of early atherosclerotis regression. Atheroscler Thromb Vasc Biol 27 (2006) 175-181
52. Baumgartner, Sidler C., Mosso M., et al. Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease. Stroke 34 (2003) 653-659
53. Micieli G. Vascular dementia. Neurol Sci 27 suppl 1 (2006) S37-S39
54. Lechat P.H. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 18 (1988) 1148-1152
55. Erkinjuntti T. Vascular cognitive deterioration and stroke. Cerebrovasc Dis 24 suppl 1 (2007) 189-194
56. Horowitz D., Tuhrim S., Weinberger J.M., and Rudolph S.H. Mechanisms in lacunar infarction. Stroke 23 (1992) 325-327
57. McGuinness B., Todd S., Passmore A.P., and Bullock R. Systematic review: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. J Neurol Neurosurg Psychiatry 79 (2008) 4-5
58. O'Sullivan M. Leukoaraiosis. Pract Neurol 8 (2008) 26-38
59. Garcia J.H. The neuropathology of stroke. Hum Pathol 6 (1975) 583-598
60. Petito C.K., and Pulsinelli W.A. Sequential development of reversible and irreversible neuronal damage following cerebral ischemia. J Neuropathol Exp Neurol 43 (1984) 141-153
61. Petito C.K. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37 (1987) 1281-1286
62. Caplan L.R. Stroke treatment: Promising but still struggling. J Am Med Assoc 279 (1998) 1304-1306
63. Fisher C.M. Capsular infarcts: The underlying vascular lesions. Arch Neurol 36 (1979) 65-73
64. Russell R.W.R. Observations on intracerebral neurysms. Brain 86 (1963) 425-442
65. Challa V.R., Moody D.M., and Bell M.A. Charcot-Bouchard aneurysm controversy: Impact of a new histological technique. J Neuropathol Exp Neurol 52 (1992) 264-271
66. Brisman J.L., Song J.K., and Newell D.W. Cerebral aneurysms. N Engl J Med 355 (2006) 928-939
67. Sasaki O: Clinicopathological study of dissecting aneurysms of the intracranial vertebral artery. J Neurosurg 75:874-882
68. McCormick W.F. The pathology of vascular (arteriovenous) malformations. J Neurosurg 24 (1996) 807-816
69. Brill J. Massive aneurysms at the base of the brain. Brain 92 (1969) 535-570
70. Morley T.P., and Barr H.W.K. Giant intracranial aneurysms: Diagnosis, course, and management. Clin Neurosurg 16 (1969) 73-94
71. Østergaard J.R. Risk factors in intracranial saccular aneurysms. Acta Neurol Scand 80 (1989) 81-98
72. Tekkok I.H., and Ventureyra E.C. Spontaneous intracranial hemorrhage of structural origin during the first year of life. Childs Nerv Syst 13 (1997) 154-165
73. Brown Jr. R.D., Huston J., Hornung R., et al. Screening for brain aneurysm in the familial intracranial aneurysm study: Frequency and predictors of lesion detection. J Neurosurg 108 (2008) 1132-1138
74. Liu B., Zhang J.N., and Pu P.Y. Expressions of PDGF-B and collagen type III in the remodeling of experimental saccular aneurysm in rats. Neurol Res 30 (2008) 632-638
75. Schievink W.I., Torres V.E., Wiebers D.O., and Huston III J. Intracranial arterial dolichoectasia in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8 (1997) 1298-1303
76. Stehbens W.E. Intracranial berry aneurysms in infancy. Surg Neurol 18 (1982) 58-60
77. Østergaard J.R., and Voldby B. Intracranial arterial aneurysms in children and adolescents. J Neurosurg 58 (1983) 832-837
78. Heros R.C., Zervas N.T., and Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 14 (1983) 599-608
79. Ondra S.L. The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg 73 (1990) 387-391
80. Wilkins R.H. Natural history of arteriovenous malformations of the brain. In: Barrow D.L. (Ed). Intracranial Vascular Malformations (1990), AANS Publications Committee, Park Ridge, IL
81. Gold A.P., Ransohoff J., and Carter S. Vein of Gallen malformation. Acta Neurol Scand 40 suppl (1964) 1-31
82. Golombek S.G., Ally S., and Woolf P.K. A newborn with cardiac failure secondary to a large vein of Galen malformation. South Med J 97 (2004) 516-518
83. Foix C., and Alajouanine T. La myelite necrotique subaigue. Rev Neurol 2 (1962) 1-42
84. Minami S. Spinal arteriovenous malformation: MR imaging. Radiology 169 (1988) 109-115
85. Ebara N., Asada H., and Miyagawa S. A case of multiple cavernous hemangiomas with skin and central nervous system involvement. J Dermatol 31 (2004) 835-838
86. Polymeropoulos M.H., Hurko O., Hsu F., et al. Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 48 (1997) 752-757
87. Sarraf D., Payne A.M., Kitchen N.D., et al. Familial cavernous hemangioma: An expanding ocular spectrum. Arch Ophthalmol 118 (2000) 969-973
88. Joachim C., Mori H., and Selkoe D. Amyloid b-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341 (1989) 226-230
89. Gudmundsson G. Hereditary cerebral hemorrhage with amyloidosis. Brain 95 (1972) 387-404
90. Hamaguchi T., and Yamada M. [Genetic factors for cerebral amyloid angiopathy.]. Brain Nerve 60 (2008) 1275-1283
91. Naito K.S., Sekijima Y., and Ikeda S. Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome. Amyloid 15 (2008) 275-277
92. Coria F., Castano E., and Frangione B. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease β-protein. Am J Pathol 129 (1982) 422-428
93. Levy E., and In S. Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. J Exp Med 169 (1989) 1771-1778
94. Maruyama K. Immunohisochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to b-protein and cystatin C. Stroke 21 (1990) 397-403
95. Mandybur T.I. Cerebral amyloid angiopathy: The vascular pathology and complications. J Neuropathol Exp Neurol 45 (1986) 79-90
96. Vinters H.V. Cerebral amyloid angiopathy: A critical review. Stroke 18 (1987) 311-319
97. Okazaki H., Reagan T.J., and Campbell R.J. Clinicopathologic study of primary cerebral amyloid angiopathy. Mayo Clin Proc 564 (1979) 22-31
98. Kibayashi K., Mastri A.R., and Hirsch C.S. Neuropathology of human immunodeficiency virus infection at different disease stages. Hum Pathol 27 (1996) 637-642
99. Moore P.M., and Cupps T.R. Neurological complications of vasculitis. Ann Neurol 14 (1983) 55-67
100. Andrianakos A.A., Duffy J., Suzuki M., and Sharp T.T. Transverse myelopathy in systemic lupus erythematosus. Ann Intern Med 83 (1975) 616-624
101. Benedict R.H., Shucard J.L., Zivadinov R., and Shucard D.W. Neuropsychological impairment in systemic lupus erythematosus: A comparison with multiple sclerosis. Neuropsychol Review 18 (2008) 149-166
102. Benseler S.M., and Silverman E.D. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 16 (2007) 564-571
103. Devinsky O., Petito C.K., and Alonso D.R. Clinical and neuropathological findings in systemic lupus erythrematus: The role of vasculitis, heart emboli and thrombotic thrombocytopenic purpura. Ann Neurol 23 (1988) 380-384
104. Levine S.R., and Welch K.M.A. Cerebrovascular ischemia associated with lupus anticoagulant. Stroke 18 (1987) 257-263
105. Paranthaman R., and Baldwin R.C. Treatment of psychiatric syndromes due to cerebrovascular disease. Int Rev Psychiatry 18 (2006) 453-470
106. Herath S.S., Law D.B., Stride P.J., et al. A case of primary cerebral vasculitis. Med J Aust 188 (2008) 547-549
107. Csepany T., Kollar J., Sikula J., et al. Primary cerebral angiitis: A case history and literature review of its diagnosis. Ideggyogy Sz 58 (2005) 183-189
108. Ishikawa E., Tsuboi K., Takano S., et al. Primary cerebral angiitis containing marked xanthoma cells with massive intraparenchymal involvement: Case report. Neurol Med Chir 45 (2005) 156-160
109. Bhat G., Mathur D.S., Saxena G.N., et al. Granulomatous angiitis of the central nervous system associated with herpes zoster. J Assoc Physicians India 50 (2002) 977-978
110. Rosenblum W.I., Hadfield M.G., and Young H.F. Granulomatous angiitis with preceding varicella roster. Ann Neurol 3 (1978) 374-375
111. Masson C., Henin D., Colombani J.M., and Dehen H. A case of cerebral giant-cell angiitis associated with cerebral amyloid angiopathy. Favorable evolution with corticosteroid therapy. Rev Neurol 154 (1998) 695-698
112. Streichenberger N., Girard-Madoux P., Verejan I., et al. Giant cell angiitis of the central nervous system with amyloid angiopathy. A case report and review of the literature. Clin Exp Pathol 47 (1999) 311-317
113. Bostwick D.G. Amphetamine induced cerebral vasculitis. Hum Pathol 12 (1981) 1031-1033
114. Pozzi M., Roccatagliata D., and Sterzi R. Drug abuse and intracranial hemorrhage. Neurol Sci 29 suppl 2 (2008) S269-S270
115. Lester J., Leyva A., Hoyos L., et al. Brain vasculitis associated with drugs. Rev Neurol 40 (2005) 736-738
116. Levine S.R. Cerebrovascular complications of the use of the "crack" form of Alkaloid cocaine. N Engl J Med 323 (1990) 699-704
117. Su J., Li J., Li W., et al. Cocaine induces apoptosis in cerebral vascular muscle cells: Potential roles in strokes and brain damage. Eur J Pharmacol 482 (2003) 61-66
118. Treadwell S.D., and Robinson T.G. Cocaine use and stroke. Postgrad Med J 83 (2007) 389-394
119. Elliott D. Migraine and stroke: Current perspectives. Neurol Res 30 (2008) 801-812
120. Jouvent E., Mangin J.F., Porcher R., et al. Cortical changes in cerebral small vessel diseases: A 3D MRI study of cortical morphology in CADASIL. Brain 131 (2008) 2201-2208
121. Andreadou E., Papadimas G., and Sfagos C. A novel heterozygous mutation in the NOTCH3 gene causing CADASIL. Swiss Med Wkly 138 (2008) 614-617
122. Munoz D.G. Small vessel disease: Neuropathology. Int Psychogeriatr 15 suppl 1 (2003) 67-69
123. Rumbaugh J.A., LaDuca J.R., Shan Y., and Miller C.A. CADASIL: The dermatologic diagnosis of a neurologic disease. Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Am Acad Dermat 43 (2000) 1128-1130
124. Mrak R.E. The big eye in the 21st century: The role of electron microscopy in modern diagnostic neuropathology. J Neuropathol Exp Neurol 61 (2002) 1027-1039
125. Maeda S., Nakayama H., Isaka K., et al. Familial unusual encephalopathy of Binswanger's type without hypertension. Folia Psychiatr Neurol Jpn 30 (1976) 165-177